Assembly Biosciences Inc (NASDAQ:ASMB)

56.59
Delayed Data
As of Feb 23
 +0.80 / +1.43%
Today’s Change
18.60
Today|||52-Week Range
58.68
+25.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-19.4M-23.8M-28.5M-44.3M
 
 
 
 
 
Depreciation6.2K11.0K65.0K80.3K
 
 
 
 
 
Total Other Cash Flow1.7M11.3M7.9M6.2M
 
 
 
 
 
Funds From Operations-17.7M-12.5M-20.5M-38.6M
 
 
 
 
 
Funds From/For Other Operating Expenses111.5K2.5M-1.9M-3.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-17.8M-15.0M-18.6M-34.9M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-82.0K-69.8M-8.0M
 
 
 
 
Decrease In Investments--0.005.0M44.3M
 
 
 
Capital Expenditures-6.5K-150.0K-58.3K-146.3K
 
 
 
 
 
Fixed Asset Disposal--509.4K150.000.00
 
 
 
Net Cash Flow Investing-6.5K277.4K-64.9M36.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.0016.7M81.6M152.6K
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing24.4M0.000.000.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing24.4M16.7M81.6M152.6K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash6.6M2.0M-1.9M1.5M